X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
Provided By GlobeNewswire
Last update: Sep 17, 2025
Organizational restructuring including a 50% reduction in workforce that is anticipated to result in annualized cost savings of approximately $13M
John Volpone appointed Chief Operating Officer, in addition to his current role as President
Read more at globenewswire.com
